SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network.

202211 citationsJournal Articlegreen Open Access

Authors

Pierre Cappy

Saadia Legrain-Jbilou · Établissement Français du Sang

Lila Chabli · Établissement Français du Sang

Mélissa N’Debi

Pierre Gallian · Établissement Français du Sang

Nadége Brisbarre

Josiane Pillonel

Pascal Morel · Établissement Français du Sang

Syria Laperche

Abstract

SARS-CoV-2 RNA can be detected in a small fraction of blood donors with PDI, reporting very low levels of RNA. The corresponding plasma is probably not infectious. These findings highlight the value of haemovigilance and PDI to guide blood safety strategies.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies SARS-CoV-2 detection and testing

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 20, Issue 5, pp. 362-373

DOI: 10.2450/2022.0266-21

Field-Weighted Citation Impact: 1.11